REED ELIZABETH E
Known title: SVP, GC & Corporate SecretaryCIK: 0001283303
Associated companies
Transaction History
| TVTX | ▲ Buy | Option Exercise | 37,500 | $580K | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 21,926 | $1.4M | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 13,874 | $869K | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 1,400 | $89K | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 300 | $20K | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,076 | $91K | 5/6/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,174 | $101K | 5/5/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 20,000 | $359K | 5/4/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 20,000 | $900K | 5/4/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 4,250 | $0 | 5/4/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 1,559 | $66K | 4/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 5,226 | $218K | 4/15/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 10,000 | $191K | 4/14/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 20,000 | $359K | 4/14/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 7,500 | $116K | 4/14/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 37,500 | $1.5M | 4/14/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 7,215 | $303K | 4/14/2026 | View on chart |
| TVTX | ▲ Buy | Grant | 14,000 | $0 | 4/13/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 10,000 | $155K | 4/1/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,000 | $300K | 4/1/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 10,000 | $191K | 3/16/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,000 | $281K | 3/16/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 5,679 | $156K | 2/17/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,321 | $122K | 2/17/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 10,000 | $191K | 2/17/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,485 | $80K | 2/4/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 509 | $17K | 2/4/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 7,175 | $230K | 2/3/2026 | View on chart |
| TVTX | ▲ Buy | Grant | 25,110 | $0 | 1/31/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 10,000 | $191K | 1/20/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,000 | $273K | 1/20/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 10,000 | $191K | 9/22/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,000 | $250K | 9/22/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,920 | $104K | 5/5/2025 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 4,920 | — | 5/2/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 8,000 | $188K | 2/12/2025 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 8,000 | — | 2/10/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 8,951 | $177K | 2/3/2025 | View on chart |
| TVTX | ▲ Buy | Grant | 21,500 | $0 | 1/31/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,437 | $47K | 1/22/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,387 | $51K | 9/9/2024 | View on chart |
| TVTX | ▲ Buy | Grant | 6,750 | $0 | 9/5/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,174 | $19K | 2/1/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,590 | $23K | 2/1/2024 | View on chart |
| TVTX | ▲ Buy | Grant | 25,000 | $0 | 1/31/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,062 | $18K | 1/23/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 1,815 | $27K | 9/5/2023 | View on chart |
| TVTX | ▲ Buy | Grant | 3,300 | $0 | 8/31/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 825 | $14K | 5/10/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,590 | $58K | 2/1/2023 | View on chart |
| TVTX | ▲ Buy | Grant | 20,250 | $0 | 1/31/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,062 | $44K | 1/24/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 1,050 | $23K | 5/12/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 900 | $19K | 5/10/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 1,350 | $37K | 1/31/2022 | View on chart |
| TVTX | ▲ Buy | Grant | 9,840 | $0 | 1/31/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,250 | $56K | 1/24/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 5,000 | $137K | 1/11/2022 | View on chart |
| TVTX | ▲ Buy | Grant | 5,000 | $0 | 1/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Travere Shares Drop 6.7% Ahead of New FILSPARI Data
Travere Therapeutics shares fell 6.7% following the release of new data and a patent extension for its drug FILSPARI. The company is set to present results supporting FILSPARI as a foundational treatment for IgA Nephropathy and FSGS at the upcoming ASN Kidney Week 2026. These developments provide key context for investors evaluating the drug's long-term clinical value.
Travere Shares Drop 6.7% Ahead of New FILSPARI Data. Travere Therapeutics shares fell 6.7% following the release of new data and a patent extension for its drug FILSPARI. The company is set to present results supporting FILSPARI as a foundational treatment for IgA Nephropathy and FSGS at the upcoming ASN Kidney Week 2026. These developments provide key context for investors evaluating the drug's long-term clinical value.